Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1978 May;61(5):1375–1383. doi: 10.1172/JCI109055

Inhibition of Parathyroid Hormone Secretion by 25-Hydroxycholecalciferol and 24,25-Dihydroxycholecalciferol in the Dog

Janet M Canterbury 1,2, Sam Lerman 1,2, Alice J Claflin 1,2, Helen Henry 1,2, Anthony Norman 1,2, Eric Reiss 1,2
PMCID: PMC372660  PMID: 659599

Abstract

We studied the effects of vitamin D metabolites on parathyroid hormone (PTH) secretion. Test materials were injected into the cranial thyroid artery of the dog, and immunoreactive PTH was measured frequently in serum samples from the inferior thyroid vein and the femoral vein. This model for the study of secretion had previously been validated with the use of known modulators on PTH secretion. In control experiments, injection of 100% ethanol, the vehicle in which cholecalciferol (D3) metabolites were suspended, resulted in no change in PTH secretion. Likewise, native vitamin D3, in doses ranging from 250 to 1,250 ng had no effect on PTH secretion. 25-Hydroxycholecalciferol, 25-(OH)D3, in doses of 125-240 ng, caused complete suppression of PTH secretion. When 24,25-dihydroxycholecalciferol, 24,25-(OH)2D3, was injected in doses of 50-250 ng, suppression of PTH secretion was again complete; in doses of 5 ng, injection of this metabolite resulted in significant but incomplete suppression of secretion. In doses of 50-250 ng, 1,25-(OH)2D3 strongly stimulated PTH secretion, but in a dose of 5 ng this metabolite had no effects. Injection of equal doses of 1,25-(OH)2D3 and 24,25-(OH)2D3 resulted in significant suppression of PTH secretion. Hypocalcemia-induced stimulation of PTH secretion was suppressed by 24,25-(OH)2D3 while hypercalcemia-induced suppression of PTH secretion was stimulated by 1,25-(OH)2D3. In all experiments showing suppression of PTH secretion, peripheral PTH decreased. Arguments are presented for considering the suppressive effects of D3 metabolites as physiologic modulators. However, this stimulating effect of 1,25-(OH)2D3 occurred only in pharmacologic doses and hence probably has no physiologic relevance.

Full text

PDF
1378

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arnaud C. D., Tsao H. S., Littledike T. Radioimmunoassay of human parathyroid hormone in serum. J Clin Invest. 1971 Jan;50(1):21–34. doi: 10.1172/JCI106476. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Arnaud C., Rasmussen H., Anast C. Further studies on the interrelationship between parathyroid hormone and vitamin D. J Clin Invest. 1966 Dec;45(12):1955–1964. doi: 10.1172/JCI105500. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Belsey R., Deluca H. F., Potts J. T., Jr Competitive binding assay for vitamin D and 25-OH vitamin D. J Clin Endocrinol Metab. 1971 Sep;33(3):554–557. doi: 10.1210/jcem-33-3-554. [DOI] [PubMed] [Google Scholar]
  4. Brumbaugh P. F., Haussler D. H., Bressler R., Haussler M. R. Radioreceptor assay for 1 alpha,25-dihydroxyvitamin D3. Science. 1974 Mar 15;183(4129):1089–1091. doi: 10.1126/science.183.4129.1089. [DOI] [PubMed] [Google Scholar]
  5. Brumbaugh P. F., Hughes M. R., Haussler M. R. Cytoplasmic and nuclear binding components for 1alpha25-dihydroxyvitamin D3 in chick parathyroid glands. Proc Natl Acad Sci U S A. 1975 Dec;72(12):4871–4875. doi: 10.1073/pnas.72.12.4871. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Canterbury J. M., Bricker L. A., Levey G. S., Kozlovskis P. L., Ruiz E., Zull J. E., Reiss E. Metabolism of bovine parathyroid hormone. Immunological and biological characteristics of fragments generated by liver perfusion. J Clin Invest. 1975 Jun;55(6):1245–1253. doi: 10.1172/JCI108043. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Canterbury J. M., Levey G. S., Reiss E. Activation of renal cortical adenylate cyclase by circulating immunoreactive parathyroid hormone fragments. J Clin Invest. 1973 Feb;52(2):524–527. doi: 10.1172/JCI107211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Canterbury J. M., Reiss E. Multiple immunoreactive molecular forms of parathyroid hormone in human serum. 1. Proc Soc Exp Biol Med. 1972 Sep;140(4):1393–1398. doi: 10.3181/00379727-140-36681. [DOI] [PubMed] [Google Scholar]
  9. Care A. D., Bates R. F., Pickard D. W., Peacock M., Tomilnson S., O'Riordan J. L., Mawer E. B., Taylor C. M., DeLuca H. F., Norman A. W. The effects of vitamin D metabolites and their analogues on the secretion of parathyroid hormone. Calcif Tissue Res. 1976 Aug;21 (Suppl):142–146. [PubMed] [Google Scholar]
  10. Care A. D., Sherwood L. M., Potts J. T., Jr, Aurbach G. D. Perfusion of the isolated parathyroid gland of the goat and sheep. Nature. 1966 Jan 1;209(5018):55–57. doi: 10.1038/209055a0. [DOI] [PubMed] [Google Scholar]
  11. Chertow B. S., Baylink D. J., Wergedal J. E., Su M. H., Norman A. W. Decrease in serum immunoreactive parathyroid hormone in rats and in parathyroid hormone secretion in vitro by 1,25-dihydroxycholecalciferol. J Clin Invest. 1975 Sep;56(3):668–678. doi: 10.1172/JCI108137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Cloix J. F., Ulmann A., Bachelet M., Funck-Brentano J. L. Cholecalciferol metabolites binding in porcine parathyroid glands. Steroids. 1976 Nov;28(5):743–749. doi: 10.1016/0039-128x(76)90011-8. [DOI] [PubMed] [Google Scholar]
  13. Emtage J. S., Lawson D. E., Kodicek E. The response of the small intestine to vitamin D. Isolation and properties of chick intestinal polyribosomes. Biochem J. 1974 May;140(2):239–247. doi: 10.1042/bj1400239. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Fraser D. R., Kodicek E. Regulation of 25-hydroxycholecalciferol-1-hydroxylase activity in kidney by parathyroid hormone. Nat New Biol. 1973 Feb 7;241(110):163–166. doi: 10.1038/newbio241163a0. [DOI] [PubMed] [Google Scholar]
  15. Fraser D. R., Kodicek E. Unique biosynthesis by kidney of a biological active vitamin D metabolite. Nature. 1970 Nov 21;228(5273):764–766. doi: 10.1038/228764a0. [DOI] [PubMed] [Google Scholar]
  16. Friedlander E. J., Norman A. W. Studies on the metabolism of calciferol XII. Production in vitro of 1,24,25-(OH)3-vitamin D3 and a search for its occurrence in vivo. Arch Biochem Biophys. 1975 Oct;170(2):731–738. doi: 10.1016/0003-9861(75)90171-x. [DOI] [PubMed] [Google Scholar]
  17. Gray R., Boyle I., DeLuca H. F. Vitamin D metabolism: the role of kidney tissue. Science. 1971 Jun 18;172(3989):1232–1234. doi: 10.1126/science.172.3989.1232. [DOI] [PubMed] [Google Scholar]
  18. HARRISON H. C., HARRISON H. E., PARK E. A. Vitamin D and citrate metabolism; effect of vitamin D in rats fed diets adequate in both calcium and phosphorus. Am J Physiol. 1958 Feb;192(2):432–436. doi: 10.1152/ajplegacy.1958.192.2.432. [DOI] [PubMed] [Google Scholar]
  19. Habener J. F., Powell D., Murray T. M., Mayer G. P., Potts J. T., Jr Parathyroid hormone: secretion and metabolism in vivo. Proc Natl Acad Sci U S A. 1971 Dec;68(12):2986–2991. doi: 10.1073/pnas.68.12.2986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Haddad J. G., Chyu K. J. Competitive protein-binding radioassay for 25-hydroxycholecalciferol. J Clin Endocrinol Metab. 1971 Dec;33(6):992–995. doi: 10.1210/jcem-33-6-992. [DOI] [PubMed] [Google Scholar]
  21. Haddad J. G., Jr, Min C., Walgate J., Hahn T. Competition by 24,25-dihydroxycholecalciferol in the competitive protein binding radioassay of 25-hydroxycalciferol. J Clin Endocrinol Metab. 1976 Sep;43(3):712–715. doi: 10.1210/jcem-43-3-712. [DOI] [PubMed] [Google Scholar]
  22. Henry H. L., Norman A. W. Studies on the mechanism of action of calciferol VII. Localization of 1,25-dihydroxy-vitamin D3 in chick parathyroid glands. Biochem Biophys Res Commun. 1975 Feb 17;62(4):781–788. doi: 10.1016/0006-291x(75)90391-5. [DOI] [PubMed] [Google Scholar]
  23. Llach F., Coburn J. W., Brickman A. S., Kurokawa K., Norman A. W., Canterbury J. M., Reiss E. Acute actions of 1,25-dihydroxy-vitamin D3 in normal man: effect on calcium and parathyroid status. J Clin Endocrinol Metab. 1977 Jun;44(6):1054–1060. doi: 10.1210/jcem-44-6-1054. [DOI] [PubMed] [Google Scholar]
  24. Norman A. W., Midgett R. J., Myrtle J. F., Nowicki H. G. Studies on calciferol metabolism. I. Production of vitamin D metabolite 4B from 25-OH-cholecalciferol by kidney homogenates. Biochem Biophys Res Commun. 1971 Mar 19;42(6):1082–1087. doi: 10.1016/0006-291x(71)90015-5. [DOI] [PubMed] [Google Scholar]
  25. Norman A. W. The hormone-like action of 1,25-(OH)2-cholecalciferol (a metabolite of the fat-soluble vitamin D) in the intestine. Vitam Horm. 1974;32:325–384. doi: 10.1016/s0083-6729(08)60018-7. [DOI] [PubMed] [Google Scholar]
  26. Oldham S. B., Fischer J. A., Shen L. H., Arnaud C. D. Isolation and properties of a calcium-binding protein from porcine parathyroid glands. Biochemistry. 1974 Nov 5;13(23):4790–4796. doi: 10.1021/bi00720a017. [DOI] [PubMed] [Google Scholar]
  27. Ponchon G., Kennan A. L., DeLuca H. F. "Activation" of vitamin D by the liver. J Clin Invest. 1969 Nov;48(11):2032–2037. doi: 10.1172/JCI106168. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Rasmussen H., Wong M., Bikle D., Goodman D. B. Hormonal control of the renal conversion of 25-hydroxycholecalciferol to 1,25-dihydroxycholecalciferol. J Clin Invest. 1972 Sep;51(9):2502–2504. doi: 10.1172/JCI107065. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Reiss E., Canterbury J. M., Egdahl R. H. Experience with a radioimmunoassay of parathyroid hormone in human sera. Trans Assoc Am Physicians. 1968;81:104–115. [PubMed] [Google Scholar]
  30. Silverman R., Yalow R. S. Heterogeneity of parathyroid hormone. Clinical and physiologic implications. J Clin Invest. 1973 Aug;52(8):1958–1971. doi: 10.1172/JCI107380. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Slatopolsky E., Caglar S., Pennell J. P., Taggart D. D., Canterbury J. M., Reiss E., Bricker N. S. On the pathogenesis of hyperparathyroidism in chronic experimental renal insufficiency in the dog. J Clin Invest. 1971 Mar;50(3):492–499. doi: 10.1172/JCI106517. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Tanaka Y., DeLuca H. F. Stimulation of 24,25-dihydroxyvitamin D3 production by 1,25-dihydroxyvitamin D3. Science. 1974 Mar;183(130):1198–1200. doi: 10.1126/science.183.4130.1198. [DOI] [PubMed] [Google Scholar]
  33. Taylor C. M., Hughes S. E., de Silva P. Competitive protein binding assay for 24,25-dihydroxycholecalciferol. Biochem Biophys Res Commun. 1976 Jun 21;70(4):1243–1249. doi: 10.1016/0006-291x(76)91035-4. [DOI] [PubMed] [Google Scholar]
  34. Tsai H. C., Norman A. W. Studies on the mode of action of calciferol. VI. Effect of 1,25-dihydroxy-vitamin D3 on RNA synthesis in the intestinal mucosa. Biochem Biophys Res Commun. 1973 Sep 18;54(2):622–627. doi: 10.1016/0006-291x(73)91468-x. [DOI] [PubMed] [Google Scholar]
  35. Wasserman R. H., Corradino R. A., Taylor A. N. Vitamin D-dependent calcium-binding protein. Purification and some properties. J Biol Chem. 1968 Jul 25;243(14):3978–3986. [PubMed] [Google Scholar]
  36. Wasserman R. H., Taylor A. N. Vitamin D-dependent calcium-binding protein. Response to some physiological and nutritional variables. J Biol Chem. 1968 Jul 25;243(14):3987–3993. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES